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The genus Orbivirus is the largest within the family Reoviri-
dae, consisting of 22 known virus species. Reports of novel 
orbiviruses in new animal species are expanding the list of 
known orbiviruses.2,4 Orbiviruses are known to cause severe 
diseases of livestock, with arguably the greatest of economic 
impacts caused by Bluetongue virus (BTV) in cattle and 
sheep, Epizootic hemorrhagic disease virus (EHDV) in wild 
ungulates or cattle, as well as African horse sickness virus, 
Equine encephalosis virus, and Peruvian horse sickness 
virus (PHSV) in equids.10 At least 7 serogroups of the known 
orbiviruses are endemic to Australia, infecting a wide range 
of host species, and known to cause mild to severe diseases 
in these host animals.3 However, most of these infections 
remain asymptomatic.
The most extensively studied orbivirus to date is BTV, 
and other orbiviruses share morphologic and genomic simi-
larities with BTV.13 Structurally, the outer capsid proteins 
(VP2 and VP5) are more variable than components of the 
virus core, or the nonstructural proteins. The outermost pro-
tein, VP2, is encoded by segment-2 of the double-stranded 
(ds)RNA genome, and is an appropriate target for the devel-
opment of type-specific, nucleic acid–based assays.7 The 
pan-clade orbivirus PCR, known to detect the majority of the 
orbiviruses, is based on VP2 sequence present in GenBank 
(http://www.ncbi.nlm.nih.gov/; Oakey, unpublished). The 
genome segments coding for the virus core and/or the non-
structural proteins can be used as targets for serogroup (virus 
species)-specific, reverse transcription (RT)-PCR–based 
assays.2,13
In 2011, a 2-year-old horse in northern Queensland, Aus-
tralia, was showing very mild neurologic signs. The ethyl-
enediamine tetra-acetic acid (EDTA) blood sample collected 
was submitted to Biosecurity Queensland for a disease inves-
tigation. Simultaneously, southern Australian states had 
reported cases of arboviral infections in horses with a focus 
on flaviviruses and alphaviruses.5,11,12 Considering the nature 
of these outbreaks in equids, the blood sample was tested 
with a panel of arboviral PCRs that included flavivirus,9 
alphavirus,14 and orbivirus (Oakey, unpublished). The sam-
ple tested negative for alphaviruses and orbiviruses. The 
sample tested for flavivirus was inconclusive, with respect to 
the positive control used in the assay, and, on that basis, was 
further subjected to virus isolation. With the history of circu-
lating Murray Valley encephalitis in Queensland horses,6 
virus isolation was attempted using 2 different cell lines. 
Buffy coat from the blood sample was inoculated into Aedes 
aegypti (AA) C6/36 cells and incubated at 28°C for 2 weeks. 
The inoculum from passage-1 AA cells was further subcul-
tured into BSR cells, a clone of baby hamster kidney (BHK)-
21 cells, for an additional week at 34°C with supplementation 
of 5% CO
2
. The AA and BSR cell lines were maintained in a 
minimum essential medium supplemented with 10% fetal 
bovine seruma and the following antimicrobials: penicillin 
(100 IU/mL), streptomycin (100 μg/mL), and amphotericin 
B (2 ng/mL).a At the end of passage 2 in BSR cells, cells 
showed cytopathic effect (CPE) characterized by severe 
cytoplasmic vacuolation, stringing, rounding-up, and detach-
ment. Supernatants from cell culture samples showing CPE 
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Abstract. In 2011, a 2-year-old horse in northern Queensland, Australia, was reported to have developed mild neurologic 
signs, and a blood sample was submitted for laboratory investigation. Virus isolation was performed using the blood sample, 
and an orbivirus was isolated. This was confirmed to be a strain of Elsey virus (ELSV) after transmission electron microscopy 
and nucleotide sequencing. The nucleotide sequence was compared with those in GenBank, and had 100% identity with 
ELSV previously reported from the Northern Territory, Australia. ELSV is taxonomically closely related to Peruvian horse 
sickness virus.
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were tested for flavivirus by PCR, which produced negative 
results. The samples were examined with negative staining 
transmission electron microscopy (TEM). The TEM revealed 
the presence of icosahedral particles ~60–70 nm (Fig. 1), 
suggesting the presence of an orbivirus in the cell culture 
supernatant.
Numerous orbiviruses are known to be endemic to Aus-
tralia, including viruses from the Wallal and Warrego groups 
and Corriparta virus. Members of these groups have been 
involved with diseases in several species, and some of these 
viruses are known to cause neurologic signs.3 In Queensland, 
~2,573 samples from horses with reported neurologic signs 
were submitted to Biosecurity Queensland in the period 
2010–2014, and <0.5% of these animals had a definitive 
diagnosis in terms of identifying and/or confirming the dis-
ease agent. This could indicate that arboviruses with the 
capacity to cause neurologic diseases are not being detected. 
Moreover, very little information is available for these 
viruses from horses in Australia.
During 1999, 2 horses from different locations in the 
Northern Territory (NT) of Australia (Katherine and Elsey 
Stations, Mataranka), showing signs of neurologic disease, 
were investigated. In both cases, an orbivirus, which was con-
sequently named Elsey virus (ELSV), was isolated.1 Subse-
quent nucleic acid sequencing showed that it was very similar 
to PHSV from South America, a mosquito-transmitted orbivi-
rus that causes encephalitis among horses. The 97–100% 
similarity for individual genes indicated that they both belong 
to PHSV serotype 1.1 The epidemiology of the infections 
caused by PHSV and Elsey is poorly characterized.
The Queensland horse isolate obtained in 2011 was 
tested by PHSV PCR using primers Phsv-1101F (TTTG-
CATTATGTTATCCAAATCA) and Phsv-1510R (TCAG 
AATCATAACCTAAATAACA) designed to amplify a 
410-bp fragment of segment 2 of the dsRNA fragment of 
PHSV. Briefly, viral RNA was isolated from cell culture 
supernatants showing CPE, using a robotic viral nucleic 
acid extraction kitb following the manufacturer’s instruc-
tions. PCR was performed using a 1-step RT-PCR kit,c with 
final concentrations of each primer at 400 nM, and using 5 
μL of heat-denatured (95°C for 5 min) RNA extract as tem-
plate. Reverse transcription was performed at 50°C for 30 
min, hot-start polymerase activation at 94°C for 2 min, 
amplification by 35 cycles of 94°C for 30 s, 53°C for 30 s, 
68°C for 45 s, and a final extension at 68°C for 5 min. 
Unused reaction components were removed using commer-
cial enzymed following the manufacturer’s instructions, 
and nucleotide sequencing was performed using a dideoxy-
nucleotide sequencing kit.e The products were purifiedf and 
resolved using a genetic analyzer.g
Nucleotide sequences were aligned using base-calling and 
alignment software,h and the sequence was compared to those 
in GenBank. Distance tree of BLAST results of the Queensland 
virus sequence was generated using the neighbor-joining 
method (Fig. 2). The sequence clustered with previously pub-
lished sequences representing PHSV (DQ248058) and ELSV 
(FJ225396). All 3 sequences were aligned using ClustalW 
software (alignment not shown), and only 1 nucleotide varia-
tion was observed between the Queensland isolate and the 
previously described isolate from NT (position G66A) and 
the Peruvian isolate (position A46G). On translation, the par-
tial VP2 sequence from the Queensland isolate showed 100% 
identity with the ELSV sequence from NT (FJ225396). The 
100% identity for partial VP2 outer coat protein between Aus-
tralian isolates indicates that the Queensland virus belongs to 
serotype 1. Interestingly, there was no noted identity with 
Figure 1. Transmission electron micrograph by negative 
staining showing presence of equine orbivirus, later confirmed as 
an Elsey virus. Bar = 100 nm. 100,000×.
Figure 2. Distance tree of BLAST results using neighbor-
joining method, and created within BLAST of our nucleotide 
sequence (http://www.ncbi.nlm.nih.gov/).
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VP2 of other reported orbiviruses, including BTV or EHDV, 
that are well described and represented in GenBank. The pan-
clade PCR for orbiviruses is based on VP2 sequences present 
in the GenBank database. However, with noted differences in 
VP2 of these orbiviruses compared to ELSV sequences, the 
pan-orbivirus PCR failed to detect ELSV.
Reports on retrospective serologic surveillance on sick 
and healthy horse samples collected since the 1999 incident 
in NT showed an ~11% seroprevalence for antibodies to 
ELSV by immunoglobulin G enzyme-linked immunosorbent 
assay.1 Although the possibility that ELSV causes neurologic 
syndromes in horses may be reasonably high, these viruses 
have also been isolated from healthy horses. Significant dif-
ferences between Australian ELSV and PHSV from South 
America were noted. PHSV has been reported to cause no 
CPE in mammalian cells; however, extensive CPE is 
observed in BSR cells infected with Australian ELSV, 
although this was after enrichment in AA cells. Clinically, 
these 2 viruses differ, as PHSV in South America causes high 
mortality in infected horses whereas the Australian horse 
infected with ELSV in 2011 recovered after a few weeks. 
During the 1999 incident in NT, both sick horses were eutha-
nized after the onset of illness, therefore the severity of the 
disease caused by ELSV was not fully assessed. However, in 
2011, in the absence of a definitive diagnosis, the Queensland 
horse was not euthanized and later was reported to have 
recovered from the infection.
Australian horses are known to become infected with 
viruses such as Murray Valley encephalitis virus, Equid her-
pesvirus, Hendra virus, and Kunjin virus, which is a subtype 
of West Nile virus.6 Although several of these infections are 
fatal, some are associated with neurologic syndromes. As 
new viruses are being reported over time8 and more con-
firmed cases of infections become available, it is necessary 
to consider the role of orbiviruses, especially in neurologic 
cases, to help provide definitive diagnoses. Our study 
describes ELSV infection of horses in Queensland, although 
detected 15 years after the incident in Northern Territory. 
There is a probability that the virus remained unnoticed 
either because of its transient nature in infected animals or 
because disease is an uncommon event. It is also possible 
that most of the infected horses remain normal and that the 
virus is detected infrequently because virus isolation is not 
routinely undertaken on these animals. However, more evi-
dence is required to confirm either of these theories. Overall, 
more data is required to determine the underlying rate of 
orbiviral infections in horses in Queensland. The accession 
number for the sequence submitted to GenBank is KP769592
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